Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $2.14 in the prior trading day, Fractyl Health Inc (NASDAQ: GUTS) closed at $1.61, down -24.77%%. In other words, the price has decreased by -$24.77% from its previous closing price. On the day, 6.19 million shares were traded. GUTS stock price reached its highest trading level at $1.98 during the session, while it also had its lowest trading level at $1.55.
Ratios:
Our goal is to gain a better understanding of GUTS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.50. In the meantime, Its Debt-to-Equity ratio is 9.63 whereas as Long-Term Debt/Eq ratio is at 8.84.
On February 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.
On February 27, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $26.BofA Securities initiated its Buy rating on February 27, 2024, with a $26 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 14 ’25 when Royan Ajay bought 17,901 shares for $1.28 per share. The transaction valued at 22,980 led to the insider holds 17,901 shares of the business.
Barnes Kelly Ann bought 31,000 shares of GUTS for $40,210 on Mar 14 ’25. The Director now owns 31,000 shares after completing the transaction at $1.30 per share. On Mar 13 ’25, another insider, SCHULMAN AMY W, who serves as the Director of the company, bought 8,550 shares for $1.17 each. As a result, the insider paid 9,964 and bolstered with 8,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 104810032 and an Enterprise Value of 98169384. For the stock, the TTM Price-to-Sale (P/S) ratio is 1314.21 while its Price-to-Book (P/B) ratio in mrq is 12.36. Its current Enterprise Value per Revenue stands at 1636.156 whereas that against EBITDA is -1.024.
Stock Price History:
The Beta on a monthly basis for GUTS is 1.85, which has changed by -0.6281755 over the last 52 weeks, in comparison to a change of 0.10163462 over the same period for the S&P500. Over the past 52 weeks, GUTS has reached a high of $5.34, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -4.23%, while the 200-Day Moving Average is calculated to be -17.37%.
Shares Statistics:
The stock has traded on average 301.35K shares per day over the past 3-months and 1145230 shares per day over the last 10 days, according to various share statistics. A total of 48.92M shares are outstanding, with a floating share count of 20.88M. Insiders hold about 57.37% of the company’s shares, while institutions hold 33.03% stake in the company. Shares short for GUTS as of 1748563200 were 2736593 with a Short Ratio of 9.08, compared to 1745971200 on 2668341. Therefore, it implies a Short% of Shares Outstanding of 2736593 and a Short% of Float of 11.219999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
